BLFS Merger Faces Scrutiny as Halper Sadeh LLC Investigates Deal Price for Shareholders
Market Chameleon (Wed, 22-Jul 10:30 AM)
Repligen’s $1.5B BioLife Acquisition Poised to Reshape Cell Therapy Market with Accretive Growth
Market Chameleon (Wed, 22-Jul 8:13 AM)
TD Cowen downgrades BioLife Solutions (BLFS) to a Hold
at www.tipranks.com (Wed, 22-Jul 6:05 PM)
BioLife Solutions to Be Acquired by Repligen Corporation
at www.tipranks.com (Wed, 22-Jul 5:52 PM)
Hold Rating Maintained as Repligen Acquisition Caps BioLife Upside; Price Target Cut to $31 from $33
at www.tipranks.com (Wed, 22-Jul 10:45 AM)
Repligen to buy BioLife Solutions in $1.5B stock-and-cash deal
at seekingalpha.com (Wed, 22-Jul 6:06 AM)
